Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
10/29/2020
Pfizer CentreOne | A Beginner's Guide to Technology Transfers
10/29/2020
LianBio Raises $310 Million to Accelerate New Treatments for Asian Mar...
10/29/2020
Asieris Approved for Ph 1 Trial of Bladder Cancer Drug in Australia
10/29/2020
Gracell Biotech Raises $100M in Series C Financing
10/29/2020
China's Growing Health Insurance Sector Attracts Interest
10/29/2020
AFD China: 2020 Amendments To The Chinese Patent Law
10/28/2020
Eisai and JD Health Establish JV in China to Build Health Service Plat...
10/28/2020
India's Balaxi Pharma to Establish Sourcing Arm in China
10/28/2020
BioInvent, CASI Pharma Enter Antibody Alliance
10/28/2020
Aprinoia Announces NMPA Approval to Initiate Phase 3 Trial for 18F-A...
10/28/2020
Moody's: COVID-19 to Accelerate Health Insurance Changes in China
10/28/2020
Study: Chinese Medical Costs to Continue Rise in Next Two Years
10/28/2020
Eli Lilly Saw Moderate China Revenue Surge on Sharp Volume Growth in Q...
10/28/2020
CStone and LegoChem Biosciences Enter Global Licensing Agreement for N...
10/28/2020
NMPA Approves Label Update for AstraZeneca's Forxiga (dapagliflozin)...
10/27/2020
CStone and EQRx Enter Global Strategic Partnership for Two Immune Chec...
10/27/2020
EdiGene Files IND for Its CRISPR/Cas 9 Gene-editing Hematopoietic Stem...
10/27/2020
Live Podcast - VC & Impact Investing in China: Investing in a Time of ...
10/27/2020
Simcere Pharma Gets New Shot in the Arm with $438M Hong Kong IPO
10/27/2020
CDE Seeks Comments on the Draft Measures on Transparency of Drug Evalu...
10/27/2020
NMPA Announces Designation of 100 National Drug Abuse Surveillance Pos...
10/27/2020
BioPlan - Biologics Manufacturing In China: Competition Heats Up Among...
10/27/2020
Promoting Innovation With Enhanced Protection And Enforcement Measurem...
10/27/2020
China Publishes Anti-Monopoly Guidelines on Intellectual Property
10/23/2020
Amgen's China Strategy Forward: Collaborating with Local Partners on W...
10/23/2020
China Signs Off on PRC Biosecurity Law: What This Means for Industry P...
10/23/2020
Follow WiCON|Pharma China on Twitter and Facebook for Latest Chinese P...
10/23/2020
CDE Issues the General Requirements for Oral Tablet Scoring Design and...
10/23/2020
Recent Executive Moves
10/22/2020
BioNTech to Make in Germany the Covid-19 Vaccine for China Market
Page:
159
/
719
Total number of articles:
21555
:
[First]
[<<]
[157]
[158]
[159]
[160]
[161]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit